Protagonist Therapeutics, Inc. (PTGX)

Protagonist Therapeutics Revenue

Protagonist Therapeutics had revenue of $4.71M in the quarter ending September 30, 2025, with 0.79% growth. This brings the company's revenue in the last twelve months to $209.22M, down -35.39% year-over-year. In the year 2024, Protagonist Therapeutics had annual revenue of $434.43M with 624.06% growth.

• Revenue (ttm): $209.22M
• Revenue Growth: -35.39%
• P/S Ratio: 26.81
• Revenue / Employee: $1,660,452
• Employees: 126
• Market Cap: 5.55B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	434.43M	374.43M	624.06%
Dec 31, 2023	60.00M	33.42M	125.73%
Dec 31, 2022	26.58M	-776.00K	-2.84%
Dec 31, 2021	27.36M	-1.27M	-4.44%
Dec 31, 2020	28.63M	28.40M	12,293.07%
Dec 31, 2019	231.00K	-30.69M	-99.25%
Dec 31, 2018	30.93M	10.86M	54.14%
Dec 31, 2017	20.06M	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-